Table 2 Distribution of numerical variables of the study in 79 cancerous and 10 hyperplastic nasopharyngeal tissue biopsies.
From: BCL2L12 is a Novel Biomarker for the Prediction of Short-Term Relapse in Nasopharyngeal Carcinoma
| Â | Â | Â | Percentile | ||
|---|---|---|---|---|---|
|  | Mean ± SEa | Range | 25th | 50th (median) | 75th |
BCL2L12 in tumors (c/cb) | 123.6 ± 55.9 | 0.01–3970.2 | 0.69 | 2.14 | 15.4 |
BCL2L12 in noncancer tissues (c/cb) | 267.1 ± 137.8 | 9.01–1483.7 | 58.6 | 149.3 | 224.6 |
Patient age (years) | 43.4 ± 1.9 | 10.0–80.0 | 28.0 | 44.0 | 56.0 |
DFS (months) | 31.1 ± 3.4 | 2.0–130.0 | 13.5 | 29.0 | 43.5 |
OS (months) | 35.1 ± 3.2 | 2.0–130.0 | 20.0 | 31.0 | 48.0 |